BONA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 558
EU - Europa 273
AS - Asia 199
OC - Oceania 6
AF - Africa 3
SA - Sud America 3
Totale 1.042
Nazione #
US - Stati Uniti d'America 557
IT - Italia 127
CN - Cina 77
SG - Singapore 66
SE - Svezia 51
IE - Irlanda 44
DE - Germania 11
FI - Finlandia 9
UA - Ucraina 9
JP - Giappone 8
KR - Corea 8
TR - Turchia 7
AU - Australia 6
FR - Francia 6
IN - India 6
HK - Hong Kong 5
UZ - Uzbekistan 5
ID - Indonesia 4
PH - Filippine 4
VN - Vietnam 4
BR - Brasile 3
GR - Grecia 3
OM - Oman 3
RU - Federazione Russa 3
BE - Belgio 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
IL - Israele 2
CA - Canada 1
ES - Italia 1
GB - Regno Unito 1
NL - Olanda 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 1.042
Città #
Chandler 137
Singapore 59
Dublin 44
Ashburn 38
Turin 32
Nyköping 26
Columbus 21
Beijing 19
Fairfield 15
Medford 15
Torino 13
Princeton 12
Hangzhou 11
Los Angeles 10
Ann Arbor 9
Wilmington 9
Rome 7
Santa Clara 7
Seoul 7
Cambridge 6
Guangzhou 6
Houston 6
Milan 6
Redwood City 6
Woodbridge 6
Boston 5
Dearborn 5
Hebei 5
Istanbul 5
New York 5
Chengdu 4
Helsinki 4
Jacksonville 4
Jakarta 4
Nichelino 4
San Mateo 4
Seattle 4
Sydney 4
Albignasego 3
Alessandria 3
Buffalo 3
Changsha 3
Dong Ket 3
Lappeenranta 3
Muscat 3
Stockholm 3
Verona 3
Villeurbanne 3
Abidjan 2
Athens 2
Boardman 2
Brno 2
Brussels 2
Böblingen 2
Charleston 2
Chongqing 2
Desio 2
Fremont 2
Gioia del Colle 2
Guiyang 2
Konya 2
Kunming 2
La Tour-de-Peilz 2
Las Vegas 2
Messina 2
Mumbai 2
Nishikicho 2
Novara 2
Ostfildern 2
Perth 2
Petriolo 2
Piemonte 2
Pune 2
Shiyan 2
St Petersburg 2
Tel Aviv 2
Waghäusel 2
Absecon 1
Americana 1
Bari 1
Bologna 1
Bronx 1
Central District 1
Châtillon 1
Cochin 1
Dandong 1
Falls Church 1
Fukuoka 1
Geldern 1
Hong Kong 1
Ichibacho 1
Indiana 1
Jinan 1
Katy 1
Lama Mocogno 1
Madrid 1
Muizenberg 1
Munich 1
Nanchang 1
Niles 1
Totale 695
Nome #
HLA DRB1*0415: a new possible genetic susceptibility factor for Hirata's disease 197
Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia 82
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 76
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study 73
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients 65
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment 64
Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions 56
Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication? 49
MORNING SERUM CORTISOL LEVEL PREDICTS CENTRAL ADRENAL INSUFFICIENCY DIAGNOSED BY INSULIN TOLERANCE TEST 48
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test 47
Primary pituitary lymphoma as rare cause of a pituitary mass and hypopituitarism in adulthood 45
Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. 36
The prevalence of silent acromegaly in prolactinomas is very low 36
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study 35
Neuroendocrine response to diclofenac in healthy subjects: a pilot study. 30
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy 30
Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone 28
Psychiatric disorders and anger in patients with controlled acromegaly 23
MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis 21
Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives 18
GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency? 17
Isolated anterior pituitary dysfunction in adulthood 16
null 12
Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly. 3
Totale 1.107
Categoria #
all - tutte 6.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 7 8 3 7 4 4 3 2
2020/2021123 2 9 5 6 21 7 24 16 10 1 5 17
2021/2022184 5 8 11 7 10 15 10 8 11 22 41 36
2022/2023377 27 36 5 39 34 75 13 16 49 27 33 23
2023/2024226 24 36 13 14 12 21 19 41 1 18 7 20
2024/2025140 8 46 11 70 5 0 0 0 0 0 0 0
Totale 1.107